Genprex to Present at Upcoming October Investor and Industry Conferences
- Friday, October 7, 2022, 7:00
- Finance
- Add a comment
Corporate and Clinical Presentations to Highlight Company’s Gene Therapies for Cancer and Diabetes AUSTIN, Texas, Oct. 7, 2022 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for…
About the Author
adminasapcorp has written 41552 stories on this site.